MAOLAC

Precision Proteins

Health Tech & Life Sciences
Active
Seed Tirat Carmel, Israel Founded 2018
Last updated 2026-06-18
Total raised
$4.0M
Last: Grant 2024-09
Stage
Seed
Founded
2018
Headcount
23
HQ
Tirat Carmel, Israel
Sector
Health Tech & Life Sciences

About

Maolac is developing a new line of novel, high impact Bio Functional Proteins (BFPs) that can be integrated into food, beverages, supplements and cosmetic products. The company's functional ingredients are based on a, proprietary Proteomics Discovery Platform (MAOreka) that enables the enrichment of specific groups of functional proteins. Through the use of AI tools, including NLP search algorithms and Web Scraping technologies, MAOreka examines a variety of functional protein sources, be they dairy or plant-based, finding the best potential protein combinations that carry a high bio-similarity to human breast milk. Coupled with a unique delivery system for improved absorption and protein stability, Maolac functional ingredients offer significantly better performance at lower dosages.

The company studies all the proteins participating in these metabolic/immunological pathways by a broad literature survey and search according to keywords. Doing so, Maolac can produce new protein mixtures, which will be active and precise for any desired effect, such as anti-inflammation, gut health, and many more. MAOreka™ ensures quick (1-1.5 years) and cost-effective bioactive product releases vs. the standard R&D process, which may take over a decade and cost millions.

The products are made up of two key elements – Pre-designed active protein mixtures that will give us that clear indication, and an absorption system to protect the functionality of the proteins in oral administration. Its unique methodology offers access to a stream of new BFPs (Bio Functional Proteins), each targeting a specific indication with a specific mix of active proteins. Maolac BFPs are derived either from dairy source or a plant-based one. The common theme for all - they are Human-Grade (i.e. have a high bio-similarity to human functional proteins), making them, by design, the highest performing in the market.

Funding history · 4 rounds · $4.0M total

Q&A

What is MAOLAC's primary focus?
MAOLAC is developing a new line of novel, high-impact Bio Functional Proteins (BFPs) for integration into food, beverages, supplements, and cosmetic products. These ingredients are based on their proprietary Proteomics Discovery Platform (MAOreka).
When was MAOLAC founded?
MAOLAC was founded in January 2018.
What is MAOLAC's total funding to date?
MAOLAC has raised a total of $4,050,000 USD across its funding rounds.
Which investors participated in MAOLAC's May 2022 funding round?
In May 2022, MAOLAC received funding from OurCrowd and theFoodTechLab.
Which investor participated in MAOLAC's September 2023 funding round?
In September 2023, Pascual Innoventures participated in a funding round for MAOLAC.
What was MAOLAC's most recent funding event?
MAOLAC received a Grant from the Israel Innovation Authority in September 2024.
Who is the Co-founder and CEO of MAOLAC?
Maya Ashkenazi (Otmazgin) is the Co-founder and CEO of MAOLAC.

Team · 1

Founder · Co-founder & CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Agriculture & Food TechnologiesFood TechFood Trade & ServicesFood ProcessingHealth Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Artificial IntelligenceNatural Language ProcessingBiologicalsMolecules
Target customers
Agriculture & FoodProcessed FoodsIngredientsLivestockDairy
Business model
B2BB2B2C

Highlights

1 PatentsVerified

Tags

deep-learningpetseldersfood-ingredientsathletesnatural-language-processingfoodtechbig-datanutritionsupplementsbioinformaticsartificial-intelligence
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)